AGP Executive Report
Last update: 10 hours agoVaccine Trial: A Danish university has approved a hepatitis B study in Guinea-Bissau involving 14,000 newborns, with half not receiving the birth-dose vaccine for six weeks. Guinea-Bissau officials have also reportedly approved it, while the trial remains under fierce criticism from health experts who say withholding a proven vaccine puts babies at risk. The CDC has reportedly set aside $1.6 million to fund the research. Digital Identity: Guinea-Bissau is among seven ECOWAS countries to launch the bloc’s common biometric ID card. ECOWAS aims for member states to accept it at air, land and sea borders by December 2026, potentially easing regional travel and trade. Animal Health: ECOWAS health networks met in Togo to strengthen regional surveillance and early detection of animal diseases, including avian influenza and rabies—an effort relevant to Guinea-Bissau and other member states.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
